Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen Net Income 2010-2025 | AMGN

Amgen annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Amgen net income for the quarter ending June 30, 2025 was $1.432B, a 91.96% increase year-over-year.
  • Amgen net income for the twelve months ending June 30, 2025 was $6.619B, a 111.47% increase year-over-year.
  • Amgen annual net income for 2024 was $4.09B, a 39.11% decline from 2023.
  • Amgen annual net income for 2023 was $6.717B, a 2.52% increase from 2022.
  • Amgen annual net income for 2022 was $6.552B, a 11.18% increase from 2021.
  
Amgen Annual Net Income
(Millions of US $)
2024 $4,090
2023 $6,717
2022 $6,552
2021 $5,893
2020 $7,264
2019 $7,842
2018 $8,394
2017 $1,979
2016 $7,722
2015 $6,939
2014 $5,158
2013 $5,081
2012 $4,345
2011 $3,683
2010 $4,627
2009 $4,605
Amgen Quarterly Net Income
(Millions of US $)
2025-06-30 $1,432
2025-03-31 $1,730
2024-12-31 $627
2024-09-30 $2,830
2024-06-30 $746
2024-03-31 $-113
2023-12-31 $767
2023-09-30 $1,730
2023-06-30 $1,379
2023-03-31 $2,841
2022-12-31 $1,616
2022-09-30 $2,143
2022-06-30 $1,317
2022-03-31 $1,476
2021-12-31 $1,899
2021-09-30 $1,884
2021-06-30 $464
2021-03-31 $1,646
2020-12-31 $1,615
2020-09-30 $2,021
2020-06-30 $1,803
2020-03-31 $1,825
2019-12-31 $1,703
2019-09-30 $1,968
2019-06-30 $2,179
2019-03-31 $1,992
2018-12-31 $1,928
2018-09-30 $1,859
2018-06-30 $2,296
2018-03-31 $2,311
2017-12-31 $-4,264
2017-09-30 $2,021
2017-06-30 $2,151
2017-03-31 $2,071
2016-12-31 $1,935
2016-09-30 $2,017
2016-06-30 $1,870
2016-03-31 $1,900
2015-12-31 $1,800
2015-09-30 $1,863
2015-06-30 $1,653
2015-03-31 $1,623
2014-12-31 $1,294
2014-09-30 $1,244
2014-06-30 $1,547
2014-03-31 $1,073
2013-12-31 $1,021
2013-09-30 $1,368
2013-06-30 $1,258
2013-03-31 $1,434
2012-12-31 $788
2012-09-30 $1,107
2012-06-30 $1,266
2012-03-31 $1,184
2011-12-31 $934
2011-09-30 $454
2011-06-30 $1,170
2011-03-31 $1,125
2010-12-31 $1,022
2010-09-30 $1,236
2010-06-30 $1,202
2010-03-31 $1,167
2009-12-31 $931
2009-09-30 $1,386
2009-06-30 $1,269
2009-03-31 $1,019
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $155.899B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $248.264B 18.11
Gilead Sciences (GILD) United States $142.383B 14.83
Vertex Pharmaceuticals (VRTX) United States $99.269B 25.59
Bristol Myers Squibb (BMY) United States $96.093B 7.01
GSK (GSK) United Kingdom $81.125B 9.44
CSL (CSLLY) Australia $67.683B 0.00
Regeneron Pharmaceuticals (REGN) United States $62.284B 15.15
Alnylam Pharmaceuticals (ALNY) United States $59.143B 0.00
Argenex SE (ARGX) Netherlands $43.335B 76.22
Insmed (INSM) United States $27.937B 0.00
BioNTech SE (BNTX) Germany $25.191B 0.00
Royalty Pharma (RPRX) United States $20.983B 8.20
Biogen (BIIB) United States $20.045B 8.54
Incyte (INCY) United States $16.403B 20.90
Genmab (GNMSF) Denmark $15.979B 14.15
Genmab (GMAB) Denmark $15.743B 14.35
Illumina (ILMN) United States $15.175B 23.73
Ascendis Pharma (ASND) Denmark $12.038B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.031B 15.57
Swedish Orphan Biovitrum (BIOVF) Sweden $10.947B 24.21
QIAGEN (QGEN) Netherlands $10.861B 20.82
Exelixis (EXEL) United States $10.321B 18.61
Moderna (MRNA) United States $9.622B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $9.140B 0.00
Bio-Techne Corp (TECH) United States $8.903B 32.83
Exact Sciences (EXAS) United States $8.730B 0.00
Halozyme Therapeutics (HALO) United States $8.530B 15.01
Roivant Sciences (ROIV) United Kingdom $8.085B 0.00
Guardant Health (GH) United States $7.910B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.582B 40.45
Anbio Biotechnology (NNNN) Germany $7.097B 0.00
Revolution Medicines (RVMD) United States $6.968B 0.00
Repligen (RGEN) United States $6.778B 73.92
Bio-Rad Laboratories (BIO.B) United States $6.723B 24.56
Rhythm Pharmaceuticals (RYTM) United States $6.722B 0.00
Legend Biotech (LEGN) United States $6.446B 0.00
Avidity Biosciences (RNA) United States $6.053B 0.00
Axsome Therapeutics (AXSM) United States $6.046B 0.00
Abivax SA (ABVX) France $6.023B 0.00
Nuvalent (NUVL) United States $5.403B 0.00
Merus (MRUS) Netherlands $5.057B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.991B 0.00
Alkermes (ALKS) Ireland $4.784B 13.29
Zealand Pharma (ZLDPF) Denmark $4.688B 4.63
Cytokinetics (CYTK) United States $4.570B 0.00
TG Therapeutics (TGTX) United States $4.487B 76.43
ACADIA Pharmaceuticals (ACAD) United States $4.339B 40.19
Krystal Biotech (KRYS) United States $4.251B 29.85
Telix Pharmaceuticals (TLX) Australia $4.244B 0.00
ADMA Biologics Inc (ADMA) United States $4.081B 29.48
Ascentage Pharma Group - (AAPG) China $3.974B 0.00
PTC Therapeutics (PTCT) United States $3.929B 6.53
Vaxcyte (PCVX) United States $3.927B 0.00
Arcellx (ACLX) United States $3.877B 0.00
Akero Therapeutics (AKRO) United States $3.849B 0.00
Zai Lab (ZLAB) United States $3.831B 0.00
Jyong Biotech (MENS) Taiwan $3.817B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.728B 0.00
Protagonist Therapeutics (PTGX) United States $3.545B 81.41
Apellis Pharmaceuticals (APLS) United States $3.527B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.501B 0.00
Metsera (MTSR) United States $3.487B 0.00
Scholar Rock Holding (SRRK) United States $3.247B 0.00
Kymera Therapeutics (KYMR) United States $3.137B 0.00
Ligand Pharmaceuticals (LGND) United States $3.131B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.980B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.928B 0.00
Viking Therapeutics (VKTX) United States $2.928B 0.00
Bavarian Nordic (BVNRY) Denmark $2.925B 14.21
Ultragenyx Pharmaceutical (RARE) United States $2.849B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.726B 0.00
Immunovant (IMVT) United States $2.629B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.488B 839.25
Tarsus Pharmaceuticals (TARS) United States $2.484B 0.00
Alvotech (ALVO) Luxembourg $2.448B 18.45
Liquidia Technologies (LQDA) United States $2.387B 0.00
Amicus Therapeutics (FOLD) United States $2.318B 0.00
Denali Therapeutics (DNLI) United States $2.274B 0.00
ImmunityBio (IBRX) United States $2.250B 0.00
Agios Pharmaceuticals (AGIO) United States $2.235B 0.00
IDEAYA Biosciences (IDYA) United States $2.179B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.138B 11.99
Celcuity (CELC) United States $2.098B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.097B 0.00
Disc Medicine (IRON) United States $2.078B 0.00
Belite Bio (BLTE) United States $2.074B 0.00
CG Oncology (CGON) United States $2.061B 0.00
Mesoblast (MESO) Australia $2.048B 0.00
ANI Pharmaceuticals (ANIP) United States $1.994B 17.88
Adaptive Biotechnologies (ADPT) United States $1.949B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.898B 0.00
Vericel (VCEL) United States $1.839B 303.75
Sarepta Therapeutics (SRPT) United States $1.784B 0.00
Apogee Therapeutics (APGE) United States $1.746B 0.00
Certara (CERT) United States $1.746B 31.97
Cidara Therapeutics (CDTX) United States $1.698B 0.00
Beam Therapeutics (BEAM) United States $1.683B 0.00
Twist Bioscience (TWST) United States $1.673B 0.00
Biohaven (BHVN) United States $1.664B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.643B 0.00
WAVE Life Sciences (WVE) Singapore $1.587B 0.00
Travere Therapeutics (TVTX) United States $1.555B 0.00
Edgewise Therapeutics (EWTX) United States $1.538B 0.00
Viridian Therapeutics (VRDN) United States $1.524B 0.00
Celldex Therapeutics (CLDX) United States $1.444B 0.00
Vera Therapeutics (VERA) United States $1.439B 0.00
Janux Therapeutics (JANX) United States $1.421B 0.00
Cogent Biosciences (COGT) United States $1.392B 0.00
89BIO (ETNB) United States $1.388B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.365B 0.00
NovoCure (NVCR) Jersey $1.323B 0.00
AbCellera Biologics (ABCL) Canada $1.306B 0.00
Precigen (PGEN) United States $1.269B 0.00
Pharvaris (PHVS) Netherlands $1.255B 0.00
MannKind (MNKD) United States $1.249B 37.00
GRAIL (GRAL) United States $1.228B 0.00
Dynavax Technologies (DVAX) United States $1.224B 52.20
Intellia Therapeutics (NTLA) United States $1.219B 0.00
Novavax (NVAX) United States $1.218B 3.29
CureVac (CVAC) Germany $1.211B 5.62
Pacira BioSciences (PCRX) United States $1.168B 12.38
Zymeworks (ZYME) United States $1.115B 0.00
Sionna Therapeutics (SION) United States $1.113B 0.00
Arcus Biosciences (RCUS) United States $1.105B 0.00
LENZ Therapeutics (LENZ) United States $1.102B 0.00
Structure Therapeutics (GPCR) United States $1.084B 0.00
Stoke Therapeutics (STOK) United States $1.061B 22.79
MiMedx (MDXG) United States $1.059B 23.87
CorMedix Inc (CRMD) United States $1.044B 18.65
Spyre Therapeutics (SYRE) United States $1.030B 0.00
Nuvation Bio (NUVB) United States $1.020B 0.00
Praxis Precision Medicines (PRAX) United States $1.008B 0.00
Mineralys Therapeutics (MLYS) United States $1.002B 0.00
Oric Pharmaceuticals (ORIC) United States $0.957B 0.00
Upstream Bio (UPB) United States $0.933B 0.00
Geron (GERN) United States $0.932B 0.00
Pharming Group (PHAR) Netherlands $0.918B 0.00
Trevi Therapeutics (TRVI) United States $0.904B 0.00
Urogen Pharma (URGN) United States $0.902B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.892B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
Iovance Biotherapeutics (IOVA) United States $0.887B 0.00
Immunome (IMNM) United States $0.884B 0.00
Pharming Group (PHGUF) Netherlands $0.872B 0.00
UniQure (QURE) Netherlands $0.866B 0.00
NeoGenomics (NEO) United States $0.866B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.830B 0.00
Anavex Life Sciences (AVXL) United States $0.819B 0.00
Fortrea Holdings (FTRE) United States $0.815B 14.48
Niagen Bioscience (NAGE) United States $0.801B 77.23
ArriVent BioPharma (AVBP) United States $0.795B 0.00
BGM Group (BGM) China $0.788B 0.00
Dianthus Therapeutics (DNTH) United States $0.783B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.779B 0.00
Sana Biotechnology (SANA) United States $0.766B 0.00
Oculis Holding AG (OCS) Switzerland $0.765B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.764B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.760B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.757B 0.00
Gyre Therapeutics (GYRE) United States $0.747B 155.20
Tango Therapeutics (TNGX) United States $0.743B 0.00
Nurix Therapeutics (NRIX) United States $0.729B 0.00
Zenas BioPharma (ZBIO) United States $0.716B 0.00
Arbutus Biopharma (ABUS) United States $0.700B 0.00
GH Research (GHRS) Ireland $0.697B 0.00
Tyra Biosciences (TYRA) United States $0.674B 0.00
Kura Oncology (KURA) United States $0.658B 0.00
Bicara Therapeutics (BCAX) United States $0.657B 0.00
Immatics (IMTX) Germany $0.650B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Terns Pharmaceuticals (TERN) United States $0.634B 0.00
Rezolute (RZLT) United States $0.626B 0.00
Castle Biosciences (CSTL) United States $0.619B 61.00
Vir Biotechnology (VIR) United States $0.617B 0.00
Maze Therapeutics (MAZE) United States $0.616B 0.00
Keros Therapeutics (KROS) United States $0.606B 48.10
MeiraGTx Holdings (MGTX) United States $0.603B 0.00
Palvella Therapeutics (PVLA) United States $0.595B 0.00
Rapport Therapeutics (RAPP) United States $0.584B 0.00
Gossamer Bio (GOSS) United States $0.575B 0.00
Septerna (SEPN) United States $0.566B 0.00
AnaptysBio (ANAB) United States $0.559B 0.00
Arvinas (ARVN) United States $0.554B 0.00
Verastem (VSTM) United States $0.548B 0.00
Myriad Genetics (MYGN) United States $0.541B 0.00
Cytek Biosciences (CTKB) United States $0.529B 0.00
Opthea (OPT) Australia $0.525B 0.00
MBX Biosciences (MBX) United States $0.516B 0.00
Kodiak Sciences (KOD) United States $0.511B 0.00
ATyr Pharma (ATYR) United States $0.504B 0.00
Alumis (ALMS) United States $0.497B 0.00
Prime Medicine (PRME) United States $0.489B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.484B 0.00
Tectonic Therapeutic (TECX) United States $0.481B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.476B 0.00
PureTech Health (PRTC) United States $0.474B 0.00
Eton Pharmaceuticals (ETON) United States $0.468B 0.00
Emergent Biosolutions (EBS) United States $0.465B 3.80
REGENXBIO (RGNX) United States $0.461B 0.00
Erasca (ERAS) United States $0.454B 0.00
Cullinan Therapeutics (CGEM) United States $0.451B 0.00
Prothena (PRTA) Ireland $0.449B 0.00
ITeos Therapeutics (ITOS) United States $0.448B 0.00
Solid Biosciences (SLDB) United States $0.445B 0.00
Replimune (REPL) United States $0.443B 0.00
Inventiva S.A (IVA) France $0.439B 0.00
Compass Therapeutics (CMPX) United States $0.436B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.428B 0.00
I-Mab (IMAB) United States $0.423B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.414B 0.00
XOMA Royalty (XOMA) United States $0.413B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.413B 0.00
Kamada (KMDA) Israel $0.405B 20.74
Aura Biosciences (AURA) United States $0.404B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.397B 0.00
Olema Pharmaceuticals (OLMA) United States $0.393B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.388B 0.00
Absci (ABSI) United States $0.381B 0.00
Astria Therapeutics (ATXS) United States $0.376B 0.00
Inhibrx Biosciences (INBX) United States $0.375B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.366B 0.00
Abeona Therapeutics (ABEO) United States $0.365B 7.73
Northwest Biotherapeutics (NWBO) United States $0.357B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.357B 0.00
Fulcrum Therapeutics (FULC) United States $0.353B 0.00
Benitec Biopharma (BNTC) United States $0.335B 0.00
CytomX Therapeutics (CTMX) United States $0.335B 3.62
Candel Therapeutics (CADL) United States $0.327B 0.00
Amarin (AMRN) Ireland $0.322B 0.00
Bright Minds Biosciences (DRUG) United States $0.315B 0.00
Foghorn Therapeutics (FHTX) United States $0.313B 0.00
DiaMedica Therapeutics (DMAC) United States $0.312B 0.00
Design Therapeutics (DSGN) United States $0.308B 0.00
Ocugen (OCGN) United States $0.304B 0.00
ScPharmaceuticals (SCPH) United States $0.295B 0.00
Atea Pharmaceuticals (AVIR) United States $0.290B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.288B 12.97
Neurogene (NGNE) United States $0.286B 0.00
Crescent Biopharma (CBIO) United States $0.283B 0.00
Neumora Therapeutics (NMRA) United States $0.282B 0.00
Lifecore Biomedical (LFCR) United States $0.281B 0.00
Cartesian Therapeutics (RNAC) United States $0.280B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.280B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.276B 0.00
Contineum Therapeutics (CTNM) United States $0.275B 0.00
Tvardi Therapeutics (TVRD) United States $0.274B 0.00
Vor Biopharma (VOR) $0.264B 0.00
DBV Technologies S.A (DBVT) France $0.262B 0.00
Jade Biosciences (JBIO) United States $0.262B 0.00
Puma Biotechnology (PBYI) United States $0.261B 5.29
Allogene Therapeutics (ALLO) United States $0.257B 0.00
Prima BioMed (IMMP) Australia $0.248B 0.00
Editas Medicine (EDIT) United States $0.245B 0.00
Alpha Teknova (TKNO) United States $0.245B 0.00
Adherex Technologies (FENC) United States $0.241B 0.00
Alector (ALEC) United States $0.239B 0.00
Codexis (CDXS) United States $0.237B 0.00
Annexon (ANNX) United States $0.236B 0.00
Humacyte (HUMA) United States $0.233B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.231B 0.00
Sagimet Biosciences (SGMT) United States $0.230B 0.00
EnGene Holdings (ENGN) Canada $0.223B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.222B 0.00
Adocia (ADOCY) France $0.216B 0.00
Immuneering (IMRX) United States $0.215B 0.00
Entrada Therapeutics (TRDA) United States $0.213B 0.00
AC Immune (ACIU) Switzerland $0.211B 0.00
Cognition Therapeutics (CGTX) United States $0.210B 0.00
Aardvark Therapeutics (AARD) United States $0.207B 0.00
GENFIT S.A (GNFT) France $0.205B 0.00
Monopar Therapeutics (MNPR) United States $0.198B 0.00
Innate Pharma S.A (IPHA) France $0.194B 0.00
Instil Bio (TIL) United States $0.192B 0.00
SELLAS Life Sciences (SLS) United States $0.192B 0.00
Voyager Therapeutics (VYGR) United States $0.190B 0.00
Rapt Therapeutics (RAPT) United States $0.187B 0.00
Caribou Biosciences (CRBU) United States $0.186B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.185B 0.00
C4 Therapeutics (CCCC) United States $0.183B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.182B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $0.181B 0.00
Tevogen Bio Holdings (TVGN) United States $0.181B 0.00
Ventyx Biosciences (VTYX) United States $0.177B 0.00
Tenaya Therapeutics (TNYA) United States $0.176B 0.00
Nuvectis Pharma (NVCT) United States $0.174B 0.00
Elicio Therapeutics (ELTX) United States $0.173B 0.00
Actuate Therapeutics (ACTU) United States $0.170B 0.00
Seres Therapeutics (MCRB) United States $0.169B 0.00
BioAge Labs (BIOA) United States $0.165B 0.00
Black Diamond Therapeutics (BDTX) United States $0.165B 12.61
Kyverna Therapeutics (KYTX) United States $0.163B 0.00
Sangamo Therapeutics (SGMO) United States $0.163B 0.00
Greenwich LifeSciences (GLSI) United States $0.163B 0.00
Climb Bio (CLYM) United States $0.158B 0.00
Molecular Partners AG (MOLN) Switzerland $0.157B 0.00
Nkarta (NKTX) United States $0.157B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.157B 0.00
Citius Oncology (CTOR) United States $0.156B 0.00
TuHURA Biosciences (HURA) United States $0.150B 0.00
Theratechnologies (THTX) Canada $0.149B 0.00
MaxCyte (MXCT) United States $0.148B 0.00
BioHarvest Sciences (BHST) Canada $0.148B 0.00
Agenus (AGEN) United States $0.148B 0.00
Cardiff Oncology (CRDF) United States $0.147B 0.00
Cellectis S.A (CLLS) France $0.144B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.144B 0.00
Genelux (GNLX) United States $0.143B 0.00
Forte Biosciences (FBRX) United States $0.140B 0.00
Cabaletta Bio (CABA) United States $0.140B 0.00
Anika Therapeutics (ANIK) United States $0.135B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.133B 0.00
Zura Bio (ZURA) United States $0.132B 0.00
Coherus Oncology (CHRS) United States $0.131B 0.00
Compugen (CGEN) Israel $0.129B 0.00
Alpha Cognition (ACOG) Canada $0.128B 0.00
Fate Therapeutics (FATE) United States $0.128B 0.00
Scilex Holding (SCLX) United States $0.125B 0.00
Invivyd (IVVD) United States $0.124B 0.00
Oncobiologics (OTLK) United States $0.120B 0.00
Seer (SEER) United States $0.117B 0.00
Equillium (EQ) United States $0.116B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.116B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.114B 0.00
IO Biotech (IOBT) Denmark $0.113B 0.00
Coya Therapeutics (COYA) United States $0.113B 0.00
Alto Neuroscience (ANRO) United States $0.112B 0.00
Adagene (ADAG) China $0.112B 0.00
Skye Bioscience (SKYE) United States $0.111B 0.00
Biomea Fusion (BMEA) United States $0.109B 0.00
Inovio Pharmaceuticals (INO) United States $0.108B 0.00
TScan Therapeutics (TCRX) United States $0.107B 0.00
XBiotech (XBIT) United States $0.107B 0.00
HilleVax (HLVX) United States $0.105B 0.00
23andMe Holding (MEHCQ) United States $0.105B 0.00
Spero Therapeutics (SPRO) United States $0.104B 0.00
Oncolytics Biotech (ONCY) Canada $0.103B 0.00
Elutia (ELUT) United States $0.102B 0.00
BioStem Technologies (BSEM) $0.100B 5.24
Pliant Therapeutics (PLRX) United States $0.099B 0.00
Connect Biopharma Holdings (CNTB) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.096B 0.00
VistaGen Therapeutics (VTGN) United States $0.095B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.094B 0.00
Celularity (CELU) United States $0.094B 0.00
Entera Bio (ENTX) Israel $0.090B 0.00
OKYO Pharma (OKYO) $0.090B 0.00
Nautilus Biotechnology (NAUT) United States $0.089B 0.00
Atara Biotherapeutics (ATRA) United States $0.089B 0.00
CervoMed (CRVO) United States $0.088B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.088B 0.00
Immunic (IMUX) United States $0.087B 0.00
Ovid Therapeutics (OVID) United States $0.087B 0.00
Quince Therapeutics (QNCX) United States $0.086B 0.00
Whitehawk Therapeutics (WHWK) United States $0.085B 0.00
BioXcel Therapeutics (BTAI) United States $0.084B 0.00
EXoZymes (EXOZ) United States $0.081B 0.00
Applied Therapeutics (APLT) United States $0.077B 0.00
Sutro Biopharma (STRO) United States $0.076B 0.00
ZIVO Bioscience (ZIVO) United States $0.073B 0.00
Opus Genetics (IRD) United States $0.072B 0.00
BeyondSpring (BYSI) United States $0.071B 0.00
TELA Bio (TELA) United States $0.071B 0.00
ABVC BioPharma (ABVC) United States $0.070B 0.00
Fortress Biotech (FBIO) United States $0.070B 0.00
Artiva Biotherapeutics (ARTV) United States $0.069B 0.00
Repare Therapeutics (RPTX) Canada $0.069B 0.00
MiNK Therapeutics (INKT) United States $0.069B 0.00
Aligos Therapeutics (ALGS) United States $0.068B 0.00
MediciNova (MNOV) United States $0.067B 0.00
Adverum Biotechnologies (ADVM) United States $0.066B 0.00
KALA BIO (KALA) United States $0.065B 0.00
Cue Biopharma (CUE) United States $0.065B 0.00
Genenta Science S.p.A (GNTA) Italy $0.064B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.064B 0.00
Quantum Biopharma (QNTM) Canada $0.063B 0.00
Werewolf Therapeutics (HOWL) United States $0.062B 0.00
InflaRx (IFRX) Germany $0.062B 0.00
Adicet Bio (ACET) United States $0.061B 0.00
Adlai Nortye (ANL) Cayman Islands $0.061B 0.00
Immix Biopharma (IMMX) United States $0.061B 0.00
PDS Biotechnology (PDSB) United States $0.060B 0.00
Precision BioSciences (DTIL) United States $0.059B 0.00
ALX Oncology Holdings (ALXO) United States $0.059B 0.00
INmune Bio (INMB) United States $0.057B 0.00
Earth Science Tech (ETST) United States $0.057B 0.00
ImageneBio (IMA) United States $0.055B 0.00
Clene (CLNN) United States $0.054B 0.00
X4 Pharmaceuticals (XFOR) United States $0.052B 0.00
VTv Therapeutics (VTVT) United States $0.050B 0.00
Shattuck Labs (STTK) United States $0.049B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.048B 0.00
Kalaris Therapeutics (KLRS) United States $0.048B 0.00
Jasper Therapeutics (JSPR) United States $0.047B 0.00
Lantern Pharma (LTRN) United States $0.047B 0.00
Annovis Bio (ANVS) United States $0.047B 0.00
Alterity Therapeutics - (ATHE) Australia $0.045B 0.00
Grace Therapeutics (GRCE) Canada $0.044B 0.00
Radiopharm Theranostics - (RADX) Australia $0.043B 0.00
Rani Therapeutics Holdings (RANI) United States $0.043B 0.00
PepGen (PEPG) United States $0.042B 0.00
Generation Bio (GBIO) United States $0.041B 0.00
Senti Biosciences (SNTI) United States $0.041B 0.00
Pluri (PLUR) Israel $0.041B 0.00
CalciMedica (CALC) United States $0.040B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.040B 0.00
Renovaro (RENB) United States $0.040B 0.00
Mersana Therapeutics (MRSN) United States $0.038B 0.00
OnKure Therapeutics (OKUR) United States $0.037B 0.00
Exicure (XCUR) United States $0.037B 0.00
Medicus Pharma (MDCX) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Estrella Immunopharma (ESLA) United States $0.036B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.035B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.034B 0.00
RenovoRx (RNXT) United States $0.034B 0.00
Dyadic (DYAI) United States $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Clearside Biomedical (CLSD) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.031B 0.00
Kezar Life Sciences (KZR) United States $0.029B 0.00
Promis Neurosciences (PMN) Canada $0.028B 0.00
Tharimmune (THAR) United States $0.028B 0.00
Cadrenal Therapeutics (CVKD) United States $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Tenax Therapeutics (TENX) United States $0.027B 0.00
Rein Therapeutics (RNTX) United States $0.027B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.027B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
Rallybio (RLYB) United States $0.025B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.024B 0.00
Synaptogenix (TAOX) United States $0.024B 0.00
BioAtla (BCAB) United States $0.024B 0.00
Cingulate (CING) United States $0.023B 0.00
SAB Biotherapeutics (SABS) United States $0.023B 0.00
Passage Bio (PASG) United States $0.022B 0.00
Q32 Bio (QTTB) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Allarity Therapeutics (ALLR) United States $0.021B 0.00
Curis (CRIS) United States $0.021B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.020B 0.00
Abpro Holdings (ABP) United States $0.019B 0.00
Flag Ship Acquisition (ETHZ) United States $0.019B 0.00
Bionano Genomics (BNGO) United States $0.019B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
Edesa Biotech (EDSA) Canada $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
LakeShore Biopharma (LSB) China $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.017B 0.00
Moleculin Biotech (MBRX) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Chemomab Therapeutics (CMMB) Israel $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.016B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.016B 0.00
IBio (IBIO) United States $0.015B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Imunon (IMNN) United States $0.015B 0.00
Intensity Therapeutics (INTS) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Soligenix (SNGX) United States $0.013B 0.00
HCW Biologics (HCWB) United States $0.013B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Longeveron (LGVN) United States $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
Femasys (FEMY) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Gelteq (GELS) Australia $0.012B 0.00
Beyond Air (XAIR) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Mustang Bio (MBIO) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.010B 0.00
IN8bio (INAB) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Advanced Biomed (ADVB) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
COSCIENS Biopharma (CSCI) Canada $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Novogen (KZIA) Australia $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Artelo Biosciences (ARTL) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Aptevo Therapeutics (APVO) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Psyence Biomedical (PBM) Canada $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
BRIACELL THERAP (BCTX) Canada $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Bone Biologics (BBLG) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00